Jonathan is Vice Chairman of life science investment banking at Oppenheimer & Co. Inc., where he utilizes his deep experience and extensive contacts across the healthcare spectrum to enhance Oppenheimer’s presence in the sector.
He is also a founder and general partner of the MD Anderson Focus Fund, a venture fund focused on bringing novel cancer drugs through clinical trials. He serves as chairman of the board of the center for Jewish Studies at the University of North Carolina and is on the board of the Partnership with Children.
Previously, Mr. Fassberg founded The Trout Group, an investor relations firm in the life sciences industry, where he served as chief executive officer from 1996 to 2021. Prior to founding Trout in 1996, Mr. Fassberg was a sell-side analyst at a healthcare-focused investment bank. Before his career on Wall Street, Mr. Fassberg spent four years at DuPont Pharma in various sales and marketing positions.
Mr. Fassberg holds a BS in biology and chemistry from The University of North Carolina— Chapel Hill and an MBA in finance from New York University’s Stern School of Business.
